Focus: EchoNous develops ultrasound diagnostic devices and AI-powered algorithms for cardiac, nephrology, and obstetric applications, with a focus on portable and bladder-scanning technologies. The company operates as a medical device innovator in the ultrasound space, founded in 2015 and headquartered in Redmond, WA.
Profile data last refreshed 3h ago · AI intelligence enriched 3w ago
EchoNous offers meaningful technical work in ultrasound AI and cardiac/renal diagnostics for early-career or specialist roles, but severely limited hiring and opaque financials make it a high-risk career move unless you have deep domain conviction or direct recruitment contact.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for EchoNous
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from EchoNous's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo